BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 15778694)

  • 1. Mucin-producing urothelial-type adenocarcinoma of prostate: report of two cases of a rare and diagnostically challenging entity.
    Curtis MW; Evans AJ; Srigley JR
    Mod Pathol; 2005 Apr; 18(4):585-90. PubMed ID: 15778694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary mucin-producing urothelial-type adenocarcinoma of prostate: report of 15 cases.
    Osunkoya AO; Epstein JI
    Am J Surg Pathol; 2007 Sep; 31(9):1323-9. PubMed ID: 17721186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostatic adenocarcinoma with urothelial (transitional cell) carcinoma features.
    Mai KT; Collins JP; Veinot JP
    Appl Immunohistochem Mol Morphol; 2002 Sep; 10(3):231-6. PubMed ID: 12373149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coordinate expression of cytokeratins 7 and 20 in prostate adenocarcinoma and bladder urothelial carcinoma.
    Bassily NH; Vallorosi CJ; Akdas G; Montie JE; Rubin MA
    Am J Clin Pathol; 2000 Mar; 113(3):383-8. PubMed ID: 10705819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secondary colonic adenocarcinoma of the prostate histologically mimicking prostatic ductal adenocarcinoma.
    Mai KT; Landry DC; Collins JP
    Tumori; 2002; 88(4):341-4. PubMed ID: 12400988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mucinous and secondary tumors of the prostate.
    Osunkoya AO
    Mod Pathol; 2018 Jan; 31(S1):S80-S95. PubMed ID: 29297488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High molecular weight cytokeratin antibody (clone 34betaE12): a sensitive marker for differentiation of high-grade invasive urothelial carcinoma from prostate cancer.
    Varma M; Morgan M; Amin MB; Wozniak S; Jasani B
    Histopathology; 2003 Feb; 42(2):167-72. PubMed ID: 12558749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urothelial-type adenocarcinoma of the prostate mimicking metastatic colorectal adenocarcinoma.
    Adley BP; Maxwell K; Dalton DP; Yang XJ
    Int Braz J Urol; 2006; 32(6):681-7; discussion 687-8. PubMed ID: 17201946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intestinal-type mucinous adenocarcinoma arising from the prostatic duct.
    Sakamoto N; Ohtsubo S; Iguchi A; Takeshita M; Kurozumi T
    Int J Urol; 2005 May; 12(5):509-12. PubMed ID: 15948756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mucinous adenocarcinoma of urinary bladder type arising from the prostatic urethra. Distinction from mucinous adenocarcinoma of the prostate.
    Tran KP; Epstein JI
    Am J Surg Pathol; 1996 Nov; 20(11):1346-50. PubMed ID: 8898838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunophenotype of high-grade prostatic adenocarcinoma and urothelial carcinoma.
    Genega EM; Hutchinson B; Reuter VE; Gaudin PB
    Mod Pathol; 2000 Nov; 13(11):1186-91. PubMed ID: 11106075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mucinous adenocarcinoma of the prostatic urethra after brachytherapy for prostatic adenocarcinoma: a case series.
    Zhao T; Chuang HW; Cornejo KM; Crotty RK; Dahl DM; Wszolek MF; Zlatev DV; Zietman AL; Wu CL
    Hum Pathol; 2022 Oct; 128():101-109. PubMed ID: 35926810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mesonephric remnant hyperplasia involving prostate and periprostatic tissue: findings at radical prostatectomy.
    Chen YB; Fine SW; Epstein JI
    Am J Surg Pathol; 2011 Jul; 35(7):1054-61. PubMed ID: 21606823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostate-specific antigen, high-molecular-weight cytokeratin (clone 34betaE12), and/or p63: an optimal immunohistochemical panel to distinguish poorly differentiated prostate adenocarcinoma from urothelial carcinoma.
    Kunju LP; Mehra R; Snyder M; Shah RB
    Am J Clin Pathol; 2006 May; 125(5):675-81. PubMed ID: 16707367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urothelial and prostate carcinoma metastasizing to the same lymph node: a case report and review of the literature.
    Overstreet K; Haghighi P
    Arch Pathol Lab Med; 2001 Oct; 125(10):1354-7. PubMed ID: 11570915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Value of a panel of antibodies to identify the primary origin of adenocarcinomas presenting as bladder carcinoma.
    Torenbeek R; Lagendijk JH; Van Diest PJ; Bril H; van de Molengraft FJ; Meijer CJ
    Histopathology; 1998 Jan; 32(1):20-7. PubMed ID: 9522212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Co-existence of mucin-producing urothelial-type adenocarcinoma of the prostate and inverted papilloma of the bladder.
    Mu XN; Wang SJ; Sun ZG; Zhang M; Li Z; Zhang LY
    Contemp Oncol (Pozn); 2017; 21(2):184-187. PubMed ID: 28947891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinguishing Cowper's glands from neoplastic and pseudoneoplastic lesions of prostate: immunohistochemical and ultrastructural studies.
    Saboorian MH; Huffman H; Ashfaq R; Ayala AG; Ro JY
    Am J Surg Pathol; 1997 Sep; 21(9):1069-74. PubMed ID: 9298883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary seminal vesicle carcinoma: an immunohistochemical analysis of four cases.
    Ormsby AH; Haskell R; Jones D; Goldblum JR
    Mod Pathol; 2000 Jan; 13(1):46-51. PubMed ID: 10658909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mucin-producing tumors and tumor-like lesions involving the prostate: a comprehensive review.
    Bohman KD; Osunkoya AO
    Adv Anat Pathol; 2012 Nov; 19(6):374-87. PubMed ID: 23060063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.